State Street’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.6M | Buy |
978,212
+49,153
| +5% | +$3.43M | ﹤0.01% | 1580 |
|
|
2025
Q4 | $76.1M | Sell |
929,059
-7,103
| -0.8% | -$530K | ﹤0.01% | 1502 |
|
|
2025
Q3 | $55.6M | Sell |
936,162
-44,706
| -5% | -$2.2M | ﹤0.01% | 1675 |
|
|
2025
Q2 | $39.7M | Buy |
980,868
+70,152
| +8% | +$3.16M | ﹤0.01% | 1802 |
|
|
2025
Q1 | $46.8M | Sell |
910,716
-6,140
| -0.7% | -$304K | ﹤0.01% | 1679 |
|
|
2024
Q4 | $50.8M | Buy |
916,856
+17,477
| +2% | +$794K | ﹤0.01% | 1710 |
|
|
2024
Q3 | $29.6M | Sell |
899,379
-26,260
| -3% | -$738K | ﹤0.01% | 1987 |
|
|
2024
Q2 | $25.2M | Buy |
925,639
+208,549
| +29% | +$7.01M | ﹤0.01% | 2055 |
|
|
2024
Q1 | $26.1M | Buy |
717,090
+42,259
| +6% | +$1.24M | ﹤0.01% | 2055 |
|
|
2023
Q4 | $13.7M | Buy |
674,831
+129,899
| +24% | +$2.17M | ﹤0.01% | 2416 |
|
|
2023
Q3 | $9.68M | Buy |
544,932
+124,216
| +30% | +$2.2M | ﹤0.01% | 2617 |
|
|
2023
Q2 | $7.6M | Buy |
420,716
+56,421
| +15% | +$897K | ﹤0.01% | 2790 |
|
|
2023
Q1 | $4.58M | Buy |
364,295
+17,635
| +5% | +$258K | ﹤0.01% | 3029 |
|
|
2022
Q4 | $5.08M | Buy |
346,660
+53,549
| +18% | +$886K | ﹤0.01% | 3036 |
|
|
2022
Q3 | $5.02M | Buy |
293,111
+56,595
| +24% | +$899K | ﹤0.01% | 3056 |
|
|
2022
Q2 | $3.45M | Buy |
236,516
+103,633
| +78% | +$1.56M | ﹤0.01% | 3277 |
|
|
2022
Q1 | $2.23M | Buy |
132,883
+3,141
| +2% | +$58.3K | ﹤0.01% | 3518 |
|
|
2021
Q4 | $2.92M | Buy |
129,742
+2,940
| +2% | +$76.4K | ﹤0.01% | 3502 |
|
|
2021
Q3 | $2.73M | Buy |
126,802
+7,661
| +6% | +$190K | ﹤0.01% | 3525 |
|
|
2021
Q2 | $3.45M | Buy |
119,141
+18,757
| +19% | +$586K | ﹤0.01% | 3405 |
|
|
2021
Q1 | $3.23M | Buy |
100,384
+3,500
| +4% | +$129K | ﹤0.01% | 3234 |
|
|
2020
Q4 | $4M | Buy |
+96,884
| New | +$2.76M | ﹤0.01% | 3069 |
|
Other funds holding TARS
DTC
RI
PBA
VCM
